Abstract:Alzheimer's disease (AD) is the most common form of neurodegenerative disease, which is characterized by progressive impairment of cognitive functions, especially memory. According to the age of onset, AD is further classified into early-onset AD (EOAD) and late-onset AD (LOAD), between which there are substantial differences in clinical progression and neuropathology. In recent years, the development of multimodal imaging technology and various new tracers has promoted the identification of imaging biomarkers of AD, which provides a basis for further understanding of imaging features of EOAD and LOAD. This article provides an overview of research advances in multimodal imaging studies of EOAD and LOAD by magnetic resonance imaging, single-photon emission computed tomography, and positron emission tomography, and also explores potential differences in imaging features between the two types of AD.